Low Glycemic Index Carbohydrates versus All Types of Carbohydrates for Treating Diabetes in Pregnancy: A Randomized Clinical Trial to Evaluate the Effect of Glycemic Control
Table 1
Baseline personal, clinical, and glycemic data of pregnant women studied.
Group 1 (All types of CHO) ()
Group 2 (Low GI CHO) ()
value
Age (years)a
31.80 ± 5.3
32.30 ± 4.8
0.517
Type 2 DM (%, )b
50.0 (23)
52.50 (32)
0.856
GDM (%, )b
50.0 (23)
47.50 (29)
0.789
Gestational age at admission (weeks)a
20.70 ± 6.7
22.50 ± 4.9
0.182
Plasma fasting glucose (mg/dL)c
104.10 ± 31.83
95.02 ± 13.97
0.406
Capillary fasting glucose (mg/dL)c
96.00 ± 13.91
96.25 ± 12.21
0.531
Capillary 2 h postprandial glucose (breakfast) (mg/dL)a
105.45 ± 19.50
108.76 ± 19.10
0.404
Capillary 2 h postprandial glucose (lunch) (mg/dL)a
119.16 ± 16.15
118.79 ± 21.98
0.927
Capillary 2 h postprandial glucose (dinner) (mg/dL)a
108.97 ± 12.78
116.20 ± 21.96
0.503
Insulin users (%, )b
69.60 (32)
56.70 (34)
0.192
Total insulin dose (units/day)c
29.10 ± 27.6
19.80 ± 22.5
0.078
Years diagnosed with type 2 DM (years)c, d
3.75 + 2.33
3.71 + 2.49
0.870
Oral hypoglycemic agents used before pregnancy (%, )b, d
81 (17)
85.7 (24)
0.905
aMean ± SD analyzed by Student -test.
bPercentage () analyzed by Chi square test.
cMean ± SD analyzed by Mann-Whitney test.
dWomen with type 2 DM ().
